Literature DB >> 8983027

Frequency of hippocampal formation atrophy in normal aging and Alzheimer's disease.

M J De Leon1, A E George, J Golomb, C Tarshish, A Convit, A Kluger, S De Santi, T McRae, S H Ferris, B Reisberg, C Ince, H Rusinek, M Bobinski, B Quinn, D C Miller, H M Wisniewski.   

Abstract

We used CT and MR to examine the frequency of occurrence of hippocampal formation atrophy (HA) in a research clinic population of 130 normal elderly, 72 nondemented patients with very mild memory and cognitive impairments (MCI), 73 mild Alzheimer's disease (AD) patients, and 130 patients with moderate to severe AD. HA was found in 29% of the normal elderly group and its frequency of occurrence was strongly related to increasing age. For normal elderly 60-75 years of age, 15% had HA: the proportion rose to 48% in subjects 76-90 years of age. Among the three groups of impaired patients, the frequencies of HA ranged from 78% in the MCI patients to 96% in the advanced AD group. Unlike the normal elderly group, the percentages were not related to age. In both the normal elderly group and MCI group disproportionately more males than females had HA. After controlling for learning and the effects of generalized brain changes as reflected in ventricular size, only in the normal group was HA associated with reduced delayed verbal recall performance. Follow-up examinations for 15 individuals with baseline HA. 4 who at entry were MCI and 11 probable AD, yielded clinical and neuropathologic diagnoses of AD in all cases. The results of the present study indicate that hippocampal formation atrophy is associated with memory and cognitive impairments. Further longitudinal and neuropathologic work is required to validate the relationship between hippocampal formation atrophy and AD.

Entities:  

Mesh:

Year:  1997        PMID: 8983027     DOI: 10.1016/s0197-4580(96)00213-8

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  89 in total

1.  Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment.

Authors:  C R Jack; R C Petersen; Y C Xu; P C O'Brien; G E Smith; R J Ivnik; B F Boeve; S C Waring; E G Tangalos; E Kokmen
Journal:  Neurology       Date:  1999-04-22       Impact factor: 9.910

Review 2.  Molecular brain imaging in the multimodality era.

Authors:  Julie C Price
Journal:  J Cereb Blood Flow Metab       Date:  2012-03-21       Impact factor: 6.200

Review 3.  Metabolic Alterations Associated to Brain Dysfunction in Diabetes.

Authors:  João M N Duarte
Journal:  Aging Dis       Date:  2015-10-01       Impact factor: 6.745

4.  Family history of Alzheimer disease predicts hippocampal atrophy in healthy middle-aged adults.

Authors:  O C Okonkwo; G Xu; N M Dowling; B B Bendlin; A Larue; B P Hermann; R Koscik; E Jonaitis; H A Rowley; C M Carlsson; S Asthana; M A Sager; S C Johnson
Journal:  Neurology       Date:  2012-05-16       Impact factor: 9.910

5.  Could linear MRI measurements of hippocampus differentiate normal brain aging in elderly persons from Alzheimer disease?

Authors:  Abdullah Tarroun; Marc Bonnefoy; Juliette Bouffard-Vercelli; Claire Gedeon; Bernard Vallee; François Cotton
Journal:  Surg Radiol Anat       Date:  2006-11-22       Impact factor: 1.246

6.  Hippocampal atrophy confounds template-based functional MR imaging measures of hippocampal activation in patients with mild cognitive impairment.

Authors:  C K Sandstrom; S Krishnan; M J Slavin; T-T T Tran; P M Doraiswamy; J R Petrella
Journal:  AJNR Am J Neuroradiol       Date:  2006-09       Impact factor: 3.825

7.  Predicting memory performance in normal ageing using different measures of hippocampal size.

Authors:  T C Lye; D A Grayson; H Creasey; O Piguet; H P Bennett; L J Ridley; J J Kril; G A Broe
Journal:  Neuroradiology       Date:  2005-12-20       Impact factor: 2.804

Review 8.  Neuropsychological and neuroimaging changes in preclinical Alzheimer's disease.

Authors:  Elizabeth W Twamley; Susan A Legendre Ropacki; Mark W Bondi
Journal:  J Int Neuropsychol Soc       Date:  2006-09       Impact factor: 2.892

Review 9.  Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD.

Authors:  Lisa Mosconi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-04       Impact factor: 9.236

10.  Body mass index, lifestyles, physical performance and cognitive decline: the "Treviso Longeva (TRELONG)" study.

Authors:  M Gallucci; S Mazzuco; F Ongaro; E Di Giorgi; P Mecocci; M Cesari; D Albani; G L Forloni; E Durante; G B Gajo; A Zanardo; M Siculi; L Caberlotto; C Regini
Journal:  J Nutr Health Aging       Date:  2013-04       Impact factor: 4.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.